PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2008 | 25 |
| 2009 | 42 |
| 2010 | 44 |
| 2011 | 44 |
| 2012 | 61 |
| 2013 | 88 |
| 2014 | 100 |
| 2015 | 62 |
| 2016 | 92 |
| 2017 | 126 |
| 2018 | 194 |
| 2019 | 164 |
| 2020 | 267 |
| 2021 | 316 |
| 2022 | 272 |
| 2023 | 241 |
| 2024 | 395 |
| 2025 | 378 |
| 2026 | 431 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Transl Oncol"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Single-cell transcriptomic and immune microenvironment analyses reveal a TIMP1-associated OLFM4⁺ tumor epithelial program linked to colorectal cancer progression and immune evasion.
- Leng R, Cui X, Wu X, Zhao Y, Sun L, Jin H, Li W, Lin J.
- Transl Oncol. 2026 Oct 16;74:103066. doi: 10.1016/j.tranon.2026.103066. Online ahead of print.
- PMCID: PMC13694951
Leng R, et al.Transl Oncol. 2026.PMCID: PMC13694951 -
The CARM1-YIPF2 axis drives breast cancer progression and predicts poor prognosis.
- Gao X, Zhang S, Peng W, Xu K.
- Transl Oncol. 2026 Oct 16;74:103073. doi: 10.1016/j.tranon.2026.103073. Online ahead of print.
- PMCID: PMC13694858
Gao X, et al.Transl Oncol. 2026.PMCID: PMC13694858 -
Network pharmacology and single-cell sequencing analysis of gastrodin in anticancer effects against colorectal cancer by regulating key target genes and the tumor immune microenvironment.
- Minjun Z, Dong X, Yuting Z, Zhishang L.
- Transl Oncol. 2026 Oct 15;74:103076. doi: 10.1016/j.tranon.2026.103076. Online ahead of print.
- PMCID: PMC13694878
Minjun Z, et al.Transl Oncol. 2026.PMCID: PMC13694878 -
PiRNA-Hsap_1847317 may serve as a novel biomarker of PD-1 inhibitor resistance in patients with advanced non-small cell lung cancer.
- Meng M, Yu B, Luo J, Sun H, Mo Z, He S, Ma H.
- Transl Oncol. 2026 Oct 14;74:103071. doi: 10.1016/j.tranon.2026.103071. Online ahead of print.
- PMCID: PMC13694418
Meng M, et al.Transl Oncol. 2026.PMCID: PMC13694418 -
Hypoxia-induced SATB homeobox 2 increases hypoxia-inducible factor-1-dependent tumorigenesis and drives bevacizumab resistance in lung adenocarcinoma.
- Ruan S, Wei T, Yuan G, Shen Y, Li Y, Ning J, Guo F, Chen K.
- Transl Oncol. 2026 Oct 19;74:103069. doi: 10.1016/j.tranon.2026.103069. Online ahead of print.
- PMCID: PMC13691162
Ruan S, et al.Transl Oncol. 2026.PMCID: PMC13691162 -
MSRB3 promotes gastric cancer progression and immunotherapy resistance by stabilizing GPX4 to inhibit ferroptosis.
- Lai J, Mo T, Su J, Zhang Z, Zhou X, Wang C, Zou Q, Li S, Zhuang X, Chen F, Huang Q, Cao J.
- Transl Oncol. 2026 Oct 19;74:103081. doi: 10.1016/j.tranon.2026.103081.
- PMCID: PMC13691149
Lai J, et al.Transl Oncol. 2026.PMCID: PMC13691149 -
Single-cell and spatial transcriptomics reveal a DLL4-associated tip-like endothelial niche linked to neoadjuvant chemotherapy non-response in muscle-invasive bladder cancer.
- Pan B, Zheng J, Luo Z, Hou S, Yuan C, Wang Y, Cao X, Huang L, Li M, Wang H, Shen B.
- Transl Oncol. 2026 Oct 14;74:103067. doi: 10.1016/j.tranon.2026.103067. Online ahead of print.
- PMCID: PMC13685988
Pan B, et al.Transl Oncol. 2026.PMCID: PMC13685988 -
NR3C2 suppresses triple-negative breast cancer progression by regulating mitochondrial ROS homeostasis via NDUFB3.
- Shi H, Zeng X, Guo Q, Lin J.
- Transl Oncol. 2026 Oct 14;74:103072. doi: 10.1016/j.tranon.2026.103072. Online ahead of print.
- PMCID: PMC13685989
Shi H, et al.Transl Oncol. 2026.PMCID: PMC13685989 -
Machine learning and multi-omics analyses reveal CLDN1 as a candidate marker associated with colorectal cancer invasion and nutlin-3a (-) response.
- Shan W, Li Q, Yuan W, Feng R, Hu P, Song Z, Li Y, Luo C, Lei N, Zhang H, Wang Z.
- Transl Oncol. 2026 Oct 13;74:103078. doi: 10.1016/j.tranon.2026.103078. Online ahead of print.
- PMCID: PMC13685891
Shan W, et al.Transl Oncol. 2026.PMCID: PMC13685891 -
Patient-derived gastric cancer organoids for functional precision oncology: disease-specific bottlenecks and clinical readiness.
- Mi C, Liu X, Tang X, Li G.
- Transl Oncol. 2026 Oct 13;74:103065. doi: 10.1016/j.tranon.2026.103065. Online ahead of print.
- PMCID: PMC13685995
Mi C, et al.Transl Oncol. 2026.PMCID: PMC13685995